Atlanta, GA, United States of America

Charles Gilliland

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles Gilliland

Introduction

Charles Gilliland is a notable inventor based in Atlanta, GA (US), recognized for his significant contributions to medical technology. With a total of 4 patents, he has developed innovative solutions aimed at improving patient care and outcomes.

Latest Patents

One of Gilliland's latest patents is the "Biopsy Tract Ablation System for Tumor Seeding Prevention and Cauterization." This invention features an ablation probe designed to prevent tumor seeding during biopsy procedures. The probe consists of an elongate body that can be inserted into a patient through an existing trocar needle or biopsy access cannula. It includes a tip that can heat tissue to effect cauterization, thereby stopping bleeding and reducing the risk of additional tumors. Another significant invention is a drainage catheter system that allows for adjustable length and secure placement within a patient's body, enhancing the efficiency of medical procedures.

Career Highlights

Gilliland's work at Traceless Biopsy, LLC has positioned him as a leader in the field of medical device innovation. His focus on developing technologies that address critical challenges in biopsy procedures showcases his commitment to advancing healthcare solutions.

Collaborations

He collaborates with talented individuals such as Kirk William Charles and Parth Patel, contributing to a dynamic team dedicated to pushing the boundaries of medical technology.

Conclusion

Charles Gilliland's innovative patents and contributions to medical technology reflect his dedication to improving patient care. His work continues to influence the field and inspire future advancements in medical devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…